179 related articles for article (PubMed ID: 28077919)
1. Noncanonical IFN Signaling: Mechanistic Linkage of Genetic and Epigenetic Events.
Johnson HM; Ahmed CM
Mediators Inflamm; 2016; 2016():9564814. PubMed ID: 28077919
[TBL] [Abstract][Full Text] [Related]
2. Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase.
Johnson HM; Noon-Song E; Ahmed CM
Mediators Inflamm; 2019; 2019():4143604. PubMed ID: 31275057
[TBL] [Abstract][Full Text] [Related]
3. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
4. Controlling nuclear JAKs and STATs for specific gene activation by IFNγ.
Noon-Song EN; Ahmed CM; Dabelic R; Canton J; Johnson HM
Biochem Biophys Res Commun; 2011 Jul; 410(3):648-53. PubMed ID: 21689637
[TBL] [Abstract][Full Text] [Related]
5. [Interferon signaling pathways].
Gongora C; Mechti N
Bull Cancer; 1999 Nov; 86(11):911-9. PubMed ID: 10586107
[TBL] [Abstract][Full Text] [Related]
6. IFN signaling: how a non-canonical model led to the development of IFN mimetics.
Johnson HM; Noon-Song EN; Dabelic R; Ahmed CM
Front Immunol; 2013; 4():202. PubMed ID: 23898330
[TBL] [Abstract][Full Text] [Related]
7. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
[TBL] [Abstract][Full Text] [Related]
8. Inteferons pen the JAK-STAT pathway.
Schindler C; Plumlee C
Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
[TBL] [Abstract][Full Text] [Related]
9. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
12. Steroid-like signalling by interferons: making sense of specific gene activation by cytokines.
Johnson HM; Noon-Song EN; Kemppainen K; Ahmed CM
Biochem J; 2012 Apr; 443(2):329-38. PubMed ID: 22452815
[TBL] [Abstract][Full Text] [Related]
13. How cells respond to interferons revisited: from early history to current complexity.
Stark GR
Cytokine Growth Factor Rev; 2007; 18(5-6):419-23. PubMed ID: 17683974
[TBL] [Abstract][Full Text] [Related]
14. JAKs, STATs and signal transduction in response to the interferons and other cytokines.
Briscoe J; Guschin D; Rogers NC; Watling D; Müller M; Horn F; Heinrich P; Stark GR; Kerr IM
Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):167-71. PubMed ID: 8650263
[TBL] [Abstract][Full Text] [Related]
15. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
16. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH
J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
[TBL] [Abstract][Full Text] [Related]
17. STAT activation and differential complex formation dictate selectivity of interferon responses.
Wesoly J; Szweykowska-Kulinska Z; Bluyssen HA
Acta Biochim Pol; 2007; 54(1):27-38. PubMed ID: 17351669
[TBL] [Abstract][Full Text] [Related]
18. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
19. The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: An example of Occam's Broom?
Ahmed CM; Johnson HM
JAKSTAT; 2013 Oct; 2(4):e26227. PubMed ID: 24416655
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways.
Hernandez JM; Elahi A; Clark W; Humphries LA; Wang J; Achille A; Seto E; Shibata D
DNA Cell Biol; 2015 Aug; 34(8):541-9. PubMed ID: 26061044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
